 | • レポートコード：QYR9ST04005 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、X連鎖低リン血症の世界市場について調査・分析し、X連鎖低リン血症の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（薬、矯正手術、その他）、用途別（病院、診療所、診断センター、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界のX連鎖低リン血症市場動向 ・主要企業別マーケットシェア ・X連鎖低リン血症の種類別市場規模2014-2019 （薬、矯正手術、その他） ・X連鎖低リン血症の用途別市場規模2014-2019 （病院、診療所、診断センター、その他） ・X連鎖低リン血症の北米市場：主要企業・種類別/用途別市場規模 ・X連鎖低リン血症のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・X連鎖低リン血症の中国市場：主要企業・種類別/用途別市場規模 ・X連鎖低リン血症の日本国内市場：主要企業・種類別/用途別市場規模 ・X連鎖低リン血症の東南アジア市場：主要企業・種類別/用途別市場規模 ・X連鎖低リン血症のインド市場：主要企業・種類別/用途別市場規模 ・X連鎖低リン血症の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Ultragenyx Pharmaceutical、Kyowa Hakko Kirin、Nestle、Merck、Pfizer、Roche、Koninklijke DSM、ADM Alliance Nutrition、Eli Lily、Validus Pharmaceuticals） ・X連鎖低リン血症の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
X-Linked Hypophosphatemia (XLH) is a genetic disorder characterized by low levels of phosphate in the blood. Phosphate levels in the blood are low as phosphate is abnormally processed in kidneys, which causes a loss of phosphate in urine and leads to soft and weak bones.Geographically, the Americas is anticipated to dominate the global X-linked hypophosphatemia market owing to a well-developed healthcare sector, rising prevalence of X-linked hypophosphatemia, and growing demand for vitamin supplements. Additionally, the increasing number of patients with genetic disorders, short stature, and growing healthcare expenditure have boosted the growth of the market in the region. Additionally, increasing awareness among the people regarding the disease and well-developed technology are likely to contribute to the growth of the market.
Europe is expected to hold the second largest position in the global X-linked hypophosphatemia market. The market growth in this region is attributed to the growing prevalence of X-linked hypophosphatemia, availability of funds for research, and government support for research and development.
Asia-Pacific is anticipated to be the fastest growing region in the market due to the presence of a huge patient population, continuously developing economies, and the presence of huge opportunities in the market. Moreover, increasing investments by market players in this region also contributes to the growth of the market.
In 2018, the global X-Linked Hypophosphatemia market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global X-Linked Hypophosphatemia status, future forecast, growth opportunity, key market and key players. The study objectives are to present the X-Linked Hypophosphatemia development in United States, Europe and China.
The key players covered in this study
Ultragenyx Pharmaceutical
Kyowa Hakko Kirin
Nestle
Merck
Pfizer
Roche
Koninklijke DSM
ADM Alliance Nutrition
Eli Lily
Validus Pharmaceuticals
Market segment by Type, the product can be split into
Medication
Corrective Surgery
Others
Market segment by Application, split into
Hospitals
Clinics
Diagnostic Centers
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global X-Linked Hypophosphatemia status, future forecast, growth opportunity, key market and key players.
To present the X-Linked Hypophosphatemia development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of X-Linked Hypophosphatemia are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global X-Linked Hypophosphatemia Market Size Growth Rate by Type (2014-2025)
1.4.2 Medication
1.4.3 Corrective Surgery
1.4.4 Others
1.5 Market by Application
1.5.1 Global X-Linked Hypophosphatemia Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Diagnostic Centers
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 X-Linked Hypophosphatemia Market Size
2.2 X-Linked Hypophosphatemia Growth Trends by Regions
2.2.1 X-Linked Hypophosphatemia Market Size by Regions (2014-2025)
2.2.2 X-Linked Hypophosphatemia Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 X-Linked Hypophosphatemia Market Size by Manufacturers
3.1.1 Global X-Linked Hypophosphatemia Revenue by Manufacturers (2014-2019)
3.1.2 Global X-Linked Hypophosphatemia Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global X-Linked Hypophosphatemia Market Concentration Ratio (CR5 and HHI)
3.2 X-Linked Hypophosphatemia Key Players Head office and Area Served
3.3 Key Players X-Linked Hypophosphatemia Product/Solution/Service
3.4 Date of Enter into X-Linked Hypophosphatemia Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global X-Linked Hypophosphatemia Market Size by Type (2014-2019)
4.2 Global X-Linked Hypophosphatemia Market Size by Application (2014-2019)
5 United States
5.1 United States X-Linked Hypophosphatemia Market Size (2014-2019)
5.2 X-Linked Hypophosphatemia Key Players in United States
5.3 United States X-Linked Hypophosphatemia Market Size by Type
5.4 United States X-Linked Hypophosphatemia Market Size by Application
6 Europe
6.1 Europe X-Linked Hypophosphatemia Market Size (2014-2019)
6.2 X-Linked Hypophosphatemia Key Players in Europe
6.3 Europe X-Linked Hypophosphatemia Market Size by Type
6.4 Europe X-Linked Hypophosphatemia Market Size by Application
7 China
7.1 China X-Linked Hypophosphatemia Market Size (2014-2019)
7.2 X-Linked Hypophosphatemia Key Players in China
7.3 China X-Linked Hypophosphatemia Market Size by Type
7.4 China X-Linked Hypophosphatemia Market Size by Application
8 Japan
8.1 Japan X-Linked Hypophosphatemia Market Size (2014-2019)
8.2 X-Linked Hypophosphatemia Key Players in Japan
8.3 Japan X-Linked Hypophosphatemia Market Size by Type
8.4 Japan X-Linked Hypophosphatemia Market Size by Application
9 Southeast Asia
9.1 Southeast Asia X-Linked Hypophosphatemia Market Size (2014-2019)
9.2 X-Linked Hypophosphatemia Key Players in Southeast Asia
9.3 Southeast Asia X-Linked Hypophosphatemia Market Size by Type
9.4 Southeast Asia X-Linked Hypophosphatemia Market Size by Application
10 India
10.1 India X-Linked Hypophosphatemia Market Size (2014-2019)
10.2 X-Linked Hypophosphatemia Key Players in India
10.3 India X-Linked Hypophosphatemia Market Size by Type
10.4 India X-Linked Hypophosphatemia Market Size by Application
11 Central & South America
11.1 Central & South America X-Linked Hypophosphatemia Market Size (2014-2019)
11.2 X-Linked Hypophosphatemia Key Players in Central & South America
11.3 Central & South America X-Linked Hypophosphatemia Market Size by Type
11.4 Central & South America X-Linked Hypophosphatemia Market Size by Application
12 International Players Profiles
12.1 Ultragenyx Pharmaceutical
12.1.1 Ultragenyx Pharmaceutical Company Details
12.1.2 Company Description and Business Overview
12.1.3 X-Linked Hypophosphatemia Introduction
12.1.4 Ultragenyx Pharmaceutical Revenue in X-Linked Hypophosphatemia Business (2014-2019)
12.1.5 Ultragenyx Pharmaceutical Recent Development
12.2 Kyowa Hakko Kirin
12.2.1 Kyowa Hakko Kirin Company Details
12.2.2 Company Description and Business Overview
12.2.3 X-Linked Hypophosphatemia Introduction
12.2.4 Kyowa Hakko Kirin Revenue in X-Linked Hypophosphatemia Business (2014-2019)
12.2.5 Kyowa Hakko Kirin Recent Development
12.3 Nestle
12.3.1 Nestle Company Details
12.3.2 Company Description and Business Overview
12.3.3 X-Linked Hypophosphatemia Introduction
12.3.4 Nestle Revenue in X-Linked Hypophosphatemia Business (2014-2019)
12.3.5 Nestle Recent Development
12.4 Merck
12.4.1 Merck Company Details
12.4.2 Company Description and Business Overview
12.4.3 X-Linked Hypophosphatemia Introduction
12.4.4 Merck Revenue in X-Linked Hypophosphatemia Business (2014-2019)
12.4.5 Merck Recent Development
12.5 Pfizer
12.5.1 Pfizer Company Details
12.5.2 Company Description and Business Overview
12.5.3 X-Linked Hypophosphatemia Introduction
12.5.4 Pfizer Revenue in X-Linked Hypophosphatemia Business (2014-2019)
12.5.5 Pfizer Recent Development
12.6 Roche
12.6.1 Roche Company Details
12.6.2 Company Description and Business Overview
12.6.3 X-Linked Hypophosphatemia Introduction
12.6.4 Roche Revenue in X-Linked Hypophosphatemia Business (2014-2019)
12.6.5 Roche Recent Development
12.7 Koninklijke DSM
12.7.1 Koninklijke DSM Company Details
12.7.2 Company Description and Business Overview
12.7.3 X-Linked Hypophosphatemia Introduction
12.7.4 Koninklijke DSM Revenue in X-Linked Hypophosphatemia Business (2014-2019)
12.7.5 Koninklijke DSM Recent Development
12.8 ADM Alliance Nutrition
12.8.1 ADM Alliance Nutrition Company Details
12.8.2 Company Description and Business Overview
12.8.3 X-Linked Hypophosphatemia Introduction
12.8.4 ADM Alliance Nutrition Revenue in X-Linked Hypophosphatemia Business (2014-2019)
12.8.5 ADM Alliance Nutrition Recent Development
12.9 Eli Lily
12.9.1 Eli Lily Company Details
12.9.2 Company Description and Business Overview
12.9.3 X-Linked Hypophosphatemia Introduction
12.9.4 Eli Lily Revenue in X-Linked Hypophosphatemia Business (2014-2019)
12.9.5 Eli Lily Recent Development
12.10 Validus Pharmaceuticals
12.10.1 Validus Pharmaceuticals Company Details
12.10.2 Company Description and Business Overview
12.10.3 X-Linked Hypophosphatemia Introduction
12.10.4 Validus Pharmaceuticals Revenue in X-Linked Hypophosphatemia Business (2014-2019)
12.10.5 Validus Pharmaceuticals Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table X-Linked Hypophosphatemia Key Market Segments
Table Key Players X-Linked Hypophosphatemia Covered
Table Global X-Linked Hypophosphatemia Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global X-Linked Hypophosphatemia Market Size Market Share by Type 2014-2025
Figure Medication Figures
Table Key Players of Medication
Figure Corrective Surgery Figures
Table Key Players of Corrective Surgery
Figure Others Figures
Table Key Players of Others
Table Global X-Linked Hypophosphatemia Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Diagnostic Centers Case Studies
Figure Others Case Studies
Figure X-Linked Hypophosphatemia Report Years Considered
Table Global X-Linked Hypophosphatemia Market Size 2014-2025 (Million US$)
Figure Global X-Linked Hypophosphatemia Market Size and Growth Rate 2014-2025 (Million US$)
Table Global X-Linked Hypophosphatemia Market Size by Regions 2014-2025 (Million US$)
Table Global X-Linked Hypophosphatemia Market Size by Regions 2014-2019 (Million US$)
Table Global X-Linked Hypophosphatemia Market Share by Regions 2014-2019
Figure Global X-Linked Hypophosphatemia Market Share by Regions 2014-2019
Figure Global X-Linked Hypophosphatemia Market Share by Regions 2019
Table Market Top Trends
Table Global X-Linked Hypophosphatemia Revenue by Manufacturers (2014-2019) (Million US$)
Table Global X-Linked Hypophosphatemia Market Share by Manufacturers (2014-2019)
Figure Global X-Linked Hypophosphatemia Market Share by Manufacturers in 2018
Table Global X-Linked Hypophosphatemia Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players X-Linked Hypophosphatemia Product/Solution/Service
Table Date of Enter into X-Linked Hypophosphatemia Market
Table Mergers & Acquisitions, Expansion Plans
Table Global X-Linked Hypophosphatemia Market Size by Type (2014-2019) (Million US$)
Table Global X-Linked Hypophosphatemia Market Size Share by Type (2014-2019)
Figure Global X-Linked Hypophosphatemia Market Size Market Share by Type (2014-2019)
Table Global X-Linked Hypophosphatemia Market Size by Application (2014-2019) (Million US$)
Table Global X-Linked Hypophosphatemia Market Size Share by Application (2014-2019)
Figure Global X-Linked Hypophosphatemia Market Size Market Share by Application (2014-2019)
Figure Global X-Linked Hypophosphatemia Revenue Market Share by Application in 2018
Figure United States X-Linked Hypophosphatemia Market Size 2014-2019 (Million US$)
Table United States Key Players X-Linked Hypophosphatemia Revenue (2018-2019) (Million US$)
Table United States Key Players X-Linked Hypophosphatemia Market Share (2018-2019)
Table United States X-Linked Hypophosphatemia Market Size by Type (2014-2019) (Million US$)
Table United States X-Linked Hypophosphatemia Market Share by Type (2014-2019)
Table United States X-Linked Hypophosphatemia Market Size by Application (2014-2019) (Million US$)
Table United States X-Linked Hypophosphatemia Market Share by Application (2014-2019)
Figure Europe X-Linked Hypophosphatemia Market Size 2014-2019 (Million US$)
Table Europe Key Players X-Linked Hypophosphatemia Revenue (2018-2019) (Million US$)
Table Europe Key Players X-Linked Hypophosphatemia Market Share (2018-2019)
Table Europe X-Linked Hypophosphatemia Market Size by Type (2014-2019) (Million US$)
Table Europe X-Linked Hypophosphatemia Market Share by Type (2014-2019)
Table Europe X-Linked Hypophosphatemia Market Size by Application (2014-2019) (Million US$)
Table Europe X-Linked Hypophosphatemia Market Share by Application (2014-2019)
Figure China X-Linked Hypophosphatemia Market Size 2014-2019 (Million US$)
Table China Key Players X-Linked Hypophosphatemia Revenue (2018-2019) (Million US$)
Table China Key Players X-Linked Hypophosphatemia Market Share (2018-2019)
Table China X-Linked Hypophosphatemia Market Size by Type (2014-20189) (Million US$)
Table China X-Linked Hypophosphatemia Market Share by Type (2014-2019)
Table China X-Linked Hypophosphatemia Market Size by Application (2014-2019) (Million US$)
Table China X-Linked Hypophosphatemia Market Share by Application (2014-2019)
Figure Japan X-Linked Hypophosphatemia Market Size 2014-2019 (Million US$)
Table Japan Key Players X-Linked Hypophosphatemia Revenue (2018-2019) (Million US$)
Table Japan Key Players X-Linked Hypophosphatemia Market Share (2018-2019)
Table Japan X-Linked Hypophosphatemia Market Size by Type (2014-2019) (Million US$)
Table Japan X-Linked Hypophosphatemia Market Share by Type (2014-2019)
Table Japan X-Linked Hypophosphatemia Market Size by Application (2014-2019) (Million US$)
Table Japan X-Linked Hypophosphatemia Market Share by Application (2014-2019)
Figure Southeast Asia X-Linked Hypophosphatemia Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players X-Linked Hypophosphatemia Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players X-Linked Hypophosphatemia Market Share (2018-2019)
Table Southeast Asia X-Linked Hypophosphatemia Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia X-Linked Hypophosphatemia Market Share by Type (2014-2019)
Table Southeast Asia X-Linked Hypophosphatemia Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia X-Linked Hypophosphatemia Market Share by Application (2014-2019)
Figure India X-Linked Hypophosphatemia Market Size 2014-2019 (Million US$)
Table India Key Players X-Linked Hypophosphatemia Revenue (2018-2019) (Million US$)
Table India Key Players X-Linked Hypophosphatemia Market Share (2018-2019)
Table India X-Linked Hypophosphatemia Market Size by Type (2014-2019) (Million US$)
Table India X-Linked Hypophosphatemia Market Share by Type (2014-2019)
Table India X-Linked Hypophosphatemia Market Size by Application (2014-2019) (Million US$)
Table India X-Linked Hypophosphatemia Market Share by Application (2014-2019)
Figure Central & South America X-Linked Hypophosphatemia Market Size 2014-2019 (Million US$)
Table Central & South America Key Players X-Linked Hypophosphatemia Revenue (2018-2019) (Million US$)
Table Central & South America Key Players X-Linked Hypophosphatemia Market Share (2018-2019)
Table Central & South America X-Linked Hypophosphatemia Market Size by Type (2014-2019) (Million US$)
Table Central & South America X-Linked Hypophosphatemia Market Share by Type (2014-2019)
Table Central & South America X-Linked Hypophosphatemia Market Size by Application (2014-2019) (Million US$)
Table Central & South America X-Linked Hypophosphatemia Market Share by Application (2014-2019)
Table Ultragenyx Pharmaceutical Company Details
Table Ultragenyx Pharmaceutical Revenue in X-Linked Hypophosphatemia Business (2014-2019) (Million US$)
Figure Ultragenyx Pharmaceutical Revenue Growth Rate in X-Linked Hypophosphatemia Business (2014-2019)
Table Ultragenyx Pharmaceutical Recent Development
Table Kyowa Hakko Kirin Company Details
Table Kyowa Hakko Kirin Revenue in X-Linked Hypophosphatemia Business (2014-2019)(Million US$)
Figure Kyowa Hakko Kirin Revenue Growth Rate in X-Linked Hypophosphatemia Business (2014-2019)
Table Kyowa Hakko Kirin Recent Development
Table Nestle Company Details
Table Nestle Revenue in X-Linked Hypophosphatemia Business (2014-2019)(Million US$)
Figure Nestle Revenue Growth Rate in X-Linked Hypophosphatemia Business (2014-2019)
Table Nestle Recent Development
Table Merck Company Details
Table Merck Revenue in X-Linked Hypophosphatemia Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in X-Linked Hypophosphatemia Business (2014-2019)
Table Merck Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in X-Linked Hypophosphatemia Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in X-Linked Hypophosphatemia Business (2014-2019)
Table Pfizer Recent Development
Table Roche Company Details
Table Roche Revenue in X-Linked Hypophosphatemia Business (2014-2019)(Million US$)
Figure Roche Revenue Growth Rate in X-Linked Hypophosphatemia Business (2014-2019)
Table Roche Recent Development
Table Koninklijke DSM Company Details
Table Koninklijke DSM Revenue in X-Linked Hypophosphatemia Business (2014-2019)(Million US$)
Figure Koninklijke DSM Revenue Growth Rate in X-Linked Hypophosphatemia Business (2014-2019)
Table Koninklijke DSM Recent Development
Table ADM Alliance Nutrition Company Details
Table ADM Alliance Nutrition Revenue in X-Linked Hypophosphatemia Business (2014-2019)(Million US$)
Figure ADM Alliance Nutrition Revenue Growth Rate in X-Linked Hypophosphatemia Business (2014-2019)
Table ADM Alliance Nutrition Recent Development
Table Eli Lily Company Details
Table Eli Lily Revenue in X-Linked Hypophosphatemia Business (2014-2019)(Million US$)
Figure Eli Lily Revenue Growth Rate in X-Linked Hypophosphatemia Business (2014-2019)
Table Eli Lily Recent Development
Table Validus Pharmaceuticals Company Details
Table Validus Pharmaceuticals Revenue in X-Linked Hypophosphatemia Business (2014-2019)(Million US$)
Figure Validus Pharmaceuticals Revenue Growth Rate in X-Linked Hypophosphatemia Business (2014-2019)
Table Validus Pharmaceuticals Recent Development
Table Global X-Linked Hypophosphatemia Market Size by Regions (Million US$) 2019-2025
Figure Global X-Linked Hypophosphatemia Market Size Share by Regions (2019-2025)
Figure Global X-Linked Hypophosphatemia Market Size Share by Regions in 2025
Figure United States X-Linked Hypophosphatemia Market Size Forecast (2019-2025)(Million USD)
Figure Europe X-Linked Hypophosphatemia Market Size Forecast (2019-2025)(Million USD)
Figure China X-Linked Hypophosphatemia Market Size Forecast (2019-2025)(Million USD)
Figure Japan X-Linked Hypophosphatemia Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia X-Linked Hypophosphatemia Market Size Forecast (2019-2025)(Million USD)
Figure India X-Linked Hypophosphatemia Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America X-Linked Hypophosphatemia Market Size Forecast (2019-2025)(Million USD)
Table Global X-Linked Hypophosphatemia Market Size by Product (2019-2025) (Million US$)
Figure Global X-Linked Hypophosphatemia Market Size by Product (2019-2025)
Figure Global X-Linked Hypophosphatemia Market Size by Product in 2025
Table Global X-Linked Hypophosphatemia Market Size by Application (2019-2025) (Million US$)
Figure Global X-Linked Hypophosphatemia Market Size by Application (2019-2025)
Figure Global X-Linked Hypophosphatemia Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
酵素免疫測定法（ELISA）テストの世界市場：市場規模・現状・予測 Enzyme-linked immunosorbent assay (ELISA) is mainly used to measure antibodies, antigens, proteins, and glycoproteins in biological samples.Hospitals and diagnostic centers were the major end-users to the ELISA test market. The demand ELISA testing in this end-user segment is mainly due to factors s…- 世界のPEX（架橋結合ポリエチレン）市場：専門的調査 The linear macromolecular structure of polyethylene is crosslinked and becomes a three-dimensional network structure of PEX.The linear macromolecular structure of polyethylene becomes crosslinked and becomes a three-dimensional network structure PEX, which greatly improves the heat resistance and cr…
- 世界のPEX（架橋結合ポリエチレン）市場：専門的調査 The linear macromolecular structure of polyethylene is crosslinked and becomes a three-dimensional network structure of PEX.The linear macromolecular structure of polyethylene becomes crosslinked and becomes a three-dimensional network structure PEX, which greatly improves the heat resistance and cr…
- 薬物治療コンプライアンス管理の世界市場：市場規模・現状・予測 The medication compliance management market plays a critical role in ensuring that patients adhere to their recommended therapy. The benefits of these are an improved medical outcome and higher patient value over the lifetime. The use of next-generation technology with financial incentives like elec…
- 店頭鎮痛薬の世界市場：市場規模・現状・予測 Over-the-counter pain medication are very helpful for the person suffering from minor and major pain. As the over-the-counter are easily available without proper prescriptions and very effective to control the pain.Over-the-counter pain medication are approved product from the regulatory authority, …